Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bufei Huoxue Capsule for stable chronic obstructive pulmonary disease
ChiCTR1800018910Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Bufei Huoxue Capsule with Placebo (2 arms). Primary endpoints: Number and severity of colds or acute exacerbations, Time to first acute exacerbation after medication and 4 more. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
bufei huoxue
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR1800018910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018910.